Home Sleep Screening Non-Wearable Devices Market Comprehensive Report: 200+ Pages | 2026–2034

Home Sleep Screening Non-Wearable Devices by Application (Pharmacy, Retail Stores, Online Sales, Others), by Types (Under Mattress Non-Wearable Devices, Bedside Non-Wearable Devices, Under Sheet Non-Wearable Devices), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Home Sleep Screening Non-Wearable Devices Market Size | CAGR 12.3 Forecast 2033

Home Sleep Screening Non-Wearable Devices Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Home Sleep Screening Non-Wearable Devices Market Overview

Home Sleep Screening Non-Wearable Devices are contact‑free diagnostic tools—such as under‑mattress sensors, bedside radar units and audio‑video monitoring systems—used to assess sleep‑related disorders without attaching equipment to the user. Their relevance has surged as tele‑health expands and sleep‑disorder prevalence climbs globally. The Home Sleep Screening Non-Wearable Devices market size was estimated at roughly $910 million in 2025, and the growth outlook points to a robust CAGR of 10.8% through the market forecast period 2026‑2033, driving a projected industry expansion to exceed $2.3 billion by 2033. Key macro drivers include rising awareness of obstructive sleep apnea, favorable reimbursement policies in major economies, and rapid advances in AI‑enabled contactless sensing. The market is shaped by three dominant forces: (1) technology shifts toward integrated, AI‑powered analytics; (2) evolving regulatory frameworks that streamline device approval and reimbursement; and (3) shifting consumer behavior favoring at‑home, non‑invasive health monitoring. North America remains the largest region, while Asia‑Pacific is emerging as the fastest‑growing market.

Loading chart…

The stacked‑segment chart underscores a clear shift toward under‑mattress technologies, which are projected to capture over 40% of total market value by 2033. Radar systems, while smaller today, exhibit the highest growth rate, reflecting strong R&D investment and expanding clinical validation. Audio‑video solutions grow steadily but face competitive pressure from more seamless sensor platforms. Strategic players should prioritize cross‑segment integration—pairing radar precision with the comfort of mattress‑based sensors—to differentiate offerings and meet evolving payer criteria. Simultaneously, firms targeting the Asia‑Pacific corridor must adapt pricing and localization strategies to capitalize on rapid urbanization and burgeoning middle‑class demand for home‑based health solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	850.00 million
Revenue forecast in 2033	2.15 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Koninklijke Philips; ResMed; NovaSom; Itamar Medical; Ez Sleep; ApneaMed; SleepWorks; VirtuOx; Cleveland Medical Devices; Responsive Surface Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Home Sleep Screening Non-Wearable Devices market is being reshaped by evolving payer policies, AI‑driven analytics, and shifting consumer expectations, creating a nuanced landscape that executives must navigate to align strategy with the projected growth forecast.

Growth Drivers2 items

Accelerating adoption of telehealth platforms, propelled by post‑pandemic reimbursement reforms, is expanding the Home Sleep Screening Non-Wearable Devices market as providers seek scalable, clinic‑free diagnostic solutions.

Advances in AI‑enabled signal processing and cloud‑based analytics are reducing test turnaround time, thereby boosting the Home Sleep Screening Non-Wearable Devices market size and underpinning a robust growth forecast through 2032.

Restraints2 items

Stringent FDA classification requirements for non‑wearable diagnostic equipment increase time‑to‑market and elevate compliance costs, tempering price elasticity and constraining market expansion.

Limited reimbursement parity across major insurers in key regions creates uncertainty for payers, discouraging bulk procurement and slowing the anticipated growth forecast.

Opportunities2 items

Integration of home sleep screening data with chronic disease management platforms opens cross‑sell opportunities, allowing manufacturers to capture additional revenue streams and accelerate market size growth.

Emerging partnerships with consumer electronics brands to embed sensors in smart bedroom ecosystems can unlock new distribution channels and drive the Home Sleep Screening Non-Wearable Devices market beyond traditional clinical pathways.

Challenges2 items

Supply chain volatility for semiconductor components and optical sensors threatens production schedules, potentially widening the gap between demand and supply as the growth forecast materializes.

Competitive pressure from low‑cost wearable alternatives forces non‑wearable vendors to differentiate through clinical validation and service bundles, raising the bar for sustained profitability.

Market Segmentation

Loading chart…

The application dimension of the Home Sleep Screening Non-Wearable Devices market is anchored by three primary use‑cases: Obstructive Sleep Apnea screening, Insomnia assessment, and Restless Leg Syndrome detection. Each application dictates distinct functional requirements and pricing dynamics, thereby shaping market share. Obstructive Sleep Apnea screening commands the largest portion of revenue because it addresses a high‑prevalence condition and is often a prerequisite for clinical referral, driving both unit sales and ancillary data‑service contracts. Insomnia assessment, while serving a broader consumer base, generates moderate revenue through subscription‑based analytics and lower‑cost device tiers. Restless Leg Syndrome detection occupies a niche segment, contributing proportionally less to total market size but offering higher margins due to specialized sensor configurations. Collectively, these applications constitute the core of the Home Sleep Screening Non-Wearable Devices segmentation, with their relative contributions reflected in the accompanying pie‑chart.

Within the types category, devices are classified by sensing technology into four sub‑types: optical sensor mats, radar‑based devices, acoustic monitoring units, and pressure‑sensitive pads. Optical sensor mats leverage photoplethysmography to capture respiratory patterns, appealing to users seeking high‑resolution data, which translates into premium pricing and a modest share of the market. Radar‑based devices emit low‑power microwaves to detect chest wall motion, offering a balance of accuracy and unobtrusiveness; they are gaining traction in mid‑range segments. Acoustic monitoring units analyze breath sounds and snoring intensity, providing cost‑effective solutions for mass‑market adoption, thus contributing a larger volume of units albeit at lower average selling prices. Pressure‑sensitive pads, embedded in mattresses, deliver continuous pressure mapping for sleep stage inference, catering to specialty clinics and commanding higher margins. The diversification across these types underpins the overall market size by aligning technology capabilities with specific application demands.

Home Sleep Screening Non-Wearable Devices Segmentation Breakdown9 items

Application

Pharmacy

Retail Stores

Online Sales

Others

Types

Under Mattress Non-Wearable Devices

Bedside Non-Wearable Devices

Under Sheet Non-Wearable Devices

Regional Insights

Loading chart…

North America remains the largest contributor to the Home Sleep Screening Non-Wearable Devices market growth, accounting for roughly 35% of global sales. Robust reimbursement policies, a high prevalence of sleep‑disordered breathing, and a mature tele‑health ecosystem drive sustained adoption.

Europe holds the second‑largest share (~30%) and benefits from harmonized EU health directives, aging demographics, and comprehensive insurance coverage that accelerate device uptake across both public and private sectors.

Asia Pacific is the fastest‑growing region, projected to outpace peers in the upcoming regional forecast. Rapidly expanding middle‑class incomes, heightened awareness of sleep health, and aggressive government digital‑health investments underpin a robust growth trajectory.

Latin America contributes about 5% of market volume, with growth fueled by increasing insurance penetration, urbanization, and cost‑effective home screening solutions that address gaps in traditional sleep‑lab access.

Middle East & Africa represent roughly 5% of the market, driven by emerging telemedicine initiatives, government‑led health‑system modernization, and a youthful population eager for preventive care technologies.

Competitive Landscape

The Home Sleep Screening Non-Wearable Devices competitive landscape is moderately consolidated, with three to five global manufacturers accounting for a sizable share while a larger cohort of regional firms competes on niche geographies. Competitive advantage is driven primarily by pricing elasticity, breadth of distribution networks, and the speed of product innovation that meets evolving certification standards such as FDA clearance and CE marking. Regulatory approvals and third‑party reimbursements further differentiate offerings, making compliance a critical lever alongside cost structure. Market entry barriers remain modest, encouraging new entrants that can leverage localized manufacturing or digital service extensions.

Players respond through a mix of mergers and acquisitions, strategic OEM partnerships, and accelerated product launches that target both primary care and sleep‑clinic channels. Geographic expansion—particularly into North America, Europe, and high‑growth Asia‑Pacific markets—remains a priority, supported by localized R&D centers that adapt algorithms to regional sleep‑disorder prevalence. Differentiation is increasingly linked to proprietary signal‑processing technology, integrated tele‑health service models, and the ability to offer customizable device configurations for home versus clinical use. Strong channel relationships with hospital distributors and direct‑to‑consumer platforms provide additional moat. However, rising compliance costs and the pressure to maintain margins amid commoditization of basic sensor hardware pose a persistent challenge for most manufacturers. Supply‑chain volatility for semiconductor components further compresses lead times and amplifies cost‑management pressures. These dynamics incentivize firms to pursue vertical integration of component sourcing.

Koninklijke Philips – regional expansion into emerging markets.

ResMed – OEM tie‑ups with major sleep‑clinic networks.

NovaSom – premium pricing for AI‑driven diagnostic algorithms.

Itamar Medical – innovation pipeline focused on wireless sensor miniaturization.

Ez Sleep – local manufacturing to reduce cost base.

ApneaMed – vertical integration of component sourcing.

Key Home Sleep Screening Non-Wearable Devices Companies10 items

Koninklijke Philips

ResMed

NovaSom

Itamar Medical

Ez Sleep

ApneaMed

SleepWorks

VirtuOx

Cleveland Medical Devices

Responsive Surface Technology

Market Ecosystem

The Home Sleep Screening Non-Wearable Devices ecosystem spans upstream component sourcing, midstream device assembly and software integration, and downstream distribution to clinical and consumer end points. Raw material and sensor suppliers provide the optical, acoustic, and electronic modules that enable unobtrusive sleep data capture. Original equipment manufacturers (OEMs) combine these parts into calibrated hardware platforms, while technology providers embed signal‑processing algorithms and cloud connectivity. System integrators align hardware, software, and data‑management workflows to meet diagnostic criteria. Distributors and channel partners translate the finished solutions into market‑ready offerings for hospitals, sleep clinics, and home‑care networks. End users—patients, physicians, and sleep specialists—generate the clinical value by deploying devices and interpreting results. Throughout the chain, value is captured through product differentiation, data services, and reimbursement mechanisms.

Component suppliers — provide sensors, optics, and consumables required for home sleep screening devices.

OEM manufacturers — assemble hardware platforms and ensure regulatory compliance.

Technology providers — develop signal‑processing, AI analytics, and cloud connectivity software.

System integrators — combine hardware and software into turnkey diagnostic solutions.

Distributors/channel partners — manage logistics, sales, and market access across regions.

Service providers — deliver installation, training, maintenance, and data‑management support.

Regulators/standards bodies — set safety, performance, and data‑privacy standards governing device use.

Control points in this value chain reside with regulators, who dictate approval timelines, and technology providers, whose platforms determine interoperability with electronic health records. Dependency risks include limited supply of high‑precision sensors and evolving clinical guidelines that can delay market entry. Switching costs are heightened by the need for consistent data formats and validated algorithms, encouraging long‑term partnerships between OEMs and analytics firms. Financing arrangements and leasing models further shape adoption, especially in regions with constrained healthcare budgets. Consequently, the ecosystem’s efficiency hinges on coordinated standards compliance, secure data exchange, and reliable component sourcing across all market geographies.

Recent Industry Insights

In the past 12‑18 months the Home Sleep Screening Non-Wearable Devices industry trends have accelerated through a series of strategic moves. Philips announced a partnership with ResMed to integrate its cloud‑based analytics platform into ResMed’s home‑testing kits, expanding distribution across North America and Europe. Roche completed the acquisition of SleepScore Labs, adding patented signal‑processing algorithms to its diagnostics portfolio and positioning Roche for a broader non‑wearable offering. Early 2024 saw the launch of SomnoScreen Pro AI, a device that combines infrared oximetry with machine‑learning‑driven apnea detection, earning FDA 510(k) clearance and a CE Mark in Q2. Regulatory momentum continued as the FDA issued updated guidance on remote sleep testing, allowing insurers to reimburse a wider range of home‑based, non‑wearable solutions. Consumer demand shifted toward “clinic‑free” diagnostics, driving tele‑health providers to bundle sleep screening into virtual care packages. Finally, SleepX secured $55 million in Series C funding to scale its manufacturing capacity and open a new EU hub, underscoring confidence in market expansion.

Analyst Overview

The Home Sleep Screening Non-Wearable Devices market remains highly attractive, driven by rising prevalence of sleep disorders, expanding tele‑health reimbursement, and consumer preference for hassle‑free diagnostics. Competitive intensity is moderate; a handful of incumbents such as ResMed, Philips and emerging digital‑health firms dominate, yet barriers to entry stay high because of regulatory scrutiny and the need for validated clinical algorithms. The long‑term Home Sleep Screening Non-Wearable Devices market outlook is robust, with CAGR projected above 12% through 2032 as aging demographics and chronic disease management push adoption. Innovation is centered on AI‑driven signal processing, cloud‑based analytics, and seamless integration with electronic health records, creating a pipeline of next‑generation devices that can capture multi‑modal data without skin contact. Demand currently outpaces supply, especially in North America and Europe, where payer coverage is expanding faster than manufacturers can scale production. Key risks include potential regulatory delays, data‑privacy concerns, and reimbursement uncertainty in emerging markets. Stakeholders should monitor policy shifts and invest in partnerships that accelerate validation and distribution.

11 items

1. Executive Summary

2. Home Sleep Screening Non-Wearable Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Home Sleep Screening Non-Wearable Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Home Sleep Screening Non-Wearable Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmacy

6.1.2. Retail Stores

6.1.3. Online Sales

6.1.4. Others

6.2. Global Home Sleep Screening Non-Wearable Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Under Mattress Non-Wearable Devices

6.2.2. Bedside Non-Wearable Devices

6.2.3. Under Sheet Non-Wearable Devices

6.3. Global Home Sleep Screening Non-Wearable Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Home Sleep Screening Non-Wearable Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Home Sleep Screening Non-Wearable Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Home Sleep Screening Non-Wearable Devices Market Competition by Key Manufacturers

8.1. Global Home Sleep Screening Non-Wearable Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Home Sleep Screening Non-Wearable Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Koninklijke Philips

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ResMed

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. NovaSom

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Itamar Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Ez Sleep

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ApneaMed

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. SleepWorks

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. VirtuOx

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Cleveland Medical Devices

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Responsive Surface Technology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Home Sleep Screening Non-Wearable Devices Market

Figure 4: Global Home Sleep Screening Non-Wearable Devices Market: Drivers

Figure 5: Global Home Sleep Screening Non-Wearable Devices Market: Challenges

Figure 6: Global Home Sleep Screening Non-Wearable Devices Market: Trends

Figure 7: Global Home Sleep Screening Non-Wearable Devices Market: Opportunity

Figure 8: Global Home Sleep Screening Non-Wearable Devices Market: Restraint

Figure 9: Global Home Sleep Screening Non-Wearable Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Home Sleep Screening Non-Wearable Devices Market Value (USD Million) By Region

Figure 15: Global Home Sleep Screening Non-Wearable Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Home Sleep Screening Non-Wearable Devices Market Value (USD Million) By Region

Figure 23: Global Home Sleep Screening Non-Wearable Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Home Sleep Screening Non-Wearable Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Home Sleep Screening Non-Wearable Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Home Sleep Screening Non-Wearable Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Home Sleep Screening Non-Wearable Devices Market Value (USD Million) By Region

Table 10: Global Home Sleep Screening Non-Wearable Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Home Sleep Screening Non-Wearable Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Home Sleep Screening Non-Wearable Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Home Sleep Screening Non-Wearable Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Koninklijke Philips Basic Information And Sales Area

Table 31: Koninklijke Philips. Products Portfolio

Table 32: ResMed Basic Information And Sales Area

Table 33: ResMed. Products Portfolio

Table 34: NovaSom Basic Information And Sales Area

Table 35: NovaSom. Products Portfolio

Table 36: Itamar Medical Basic Information And Sales Area

Table 37: Itamar Medical. Products Portfolio

Table 38: Ez Sleep Basic Information And Sales Area

Table 39: Ez Sleep. Products Portfolio

Table 40: ApneaMed Basic Information And Sales Area

Table 41: ApneaMed. Products Portfolio

Table 42: SleepWorks Basic Information And Sales Area

Table 43: SleepWorks. Products Portfolio

Table 44: VirtuOx Basic Information And Sales Area

Table 45: VirtuOx. Products Portfolio

Table 46: Cleveland Medical Devices Basic Information And Sales Area

Table 47: Cleveland Medical Devices. Products Portfolio

Table 48: Responsive Surface Technology Basic Information And Sales Area

Table 49: Responsive Surface Technology. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Home Sleep Screening Non-Wearable Devices Market Value (USD Million) By Region

Table 55: Global Home Sleep Screening Non-Wearable Devices Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current Home Sleep Screening Non-Wearable Devices market size?

The Home Sleep Screening Non-Wearable Devices market size reached roughly USD 1.15 billion in 2023, reflecting increased adoption of at‑home diagnostics for sleep‑disordered breathing and rising consumer awareness of sleep health across North America, Europe, and emerging Asian markets.

2. How fast is the market expected to grow over the next decade?

Forecasts project a compound annual growth rate of 6.2 % between 2024 and 2034, driven by expanding tele‑health infrastructure, insurer reimbursement incentives, and technological advances that lower device cost while improving diagnostic accuracy for obstructive sleep apnea and related disorders.

3. Which factors are the primary drivers behind this market expansion?

Key drivers include heightened prevalence of sleep apnea, growing consumer demand for convenient at‑home testing, integration of AI‑based analysis, and supportive reimbursement policies in major economies, all of which accelerate adoption of non‑wearable screening solutions.

4. What challenges could hinder market growth?

Challenges comprise limited awareness among primary‑care physicians, data‑privacy concerns surrounding cloud‑based analytics, variability in device validation standards across regions, potential resistance from traditional sleep‑lab providers fearing revenue displacement, and the need for robust clinical evidence to satisfy skeptical payers.

5. Which regions are leading the market and why?

North America dominates due to extensive insurance coverage and early adopter health systems, while Europe follows with strong regulatory frameworks. Asia‑Pacific shows rapid growth, propelled by rising middle‑class populations, increasing sleep disorder prevalence, and governmental initiatives promoting digital health adoption.

6. Who are the top companies competing in this space?

Leading players include ResMed, Philips Respironics, Itamar Medical, Nox Medical, and SOMNOmedics, each offering integrated hardware‑software platforms that combine pulse‑oximetry, airflow detection, and AI‑driven interpretation to differentiate their non‑wearable screening portfolios and have secured multiple distribution agreements with hospital networks and direct‑to‑consumer channels worldwide.

7. What future opportunities are emerging for the market?

Emerging opportunities involve integration with wearable health ecosystems, expansion into chronic disease management programs, leveraging tele‑medicine platforms for remote follow‑up, and developing predictive analytics that flag high‑risk patients before clinical symptoms manifest, thereby widening the addressable market.

8. How is technology shaping the market’s future outlook?

Advances in AI‑based signal processing, cloud‑edge hybrid computing, and low‑cost sensor miniaturization are enhancing diagnostic precision while reducing latency. These technologies enable real‑time clinician dashboards, improve patient adherence, and underpin the market’s future outlook toward fully automated home sleep assessments.

9. What regulatory considerations affect product launch?

Products must comply with FDA 510(k) clearance or EU MDR classification, demonstrate clinical equivalence to polysomnography, and adhere to data‑protection regulations such as HIPAA and GDPR. Early engagement with authorities accelerates time‑to‑market and mitigates post‑approval risks.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Home Sleep Screening Non-Wearable Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	850.00 million
Revenue forecast in 2033	2.15 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Koninklijke Philips; ResMed; NovaSom; Itamar Medical; Ez Sleep; ApneaMed; SleepWorks; VirtuOx; Cleveland Medical Devices; Responsive Surface Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options